1. Home
  2. CHNR vs BGLC Comparison

CHNR vs BGLC Comparison

Compare CHNR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHNR
  • BGLC
  • Stock Information
  • Founded
  • CHNR N/A
  • BGLC 2017
  • Country
  • CHNR China
  • BGLC Malaysia
  • Employees
  • CHNR N/A
  • BGLC N/A
  • Industry
  • CHNR Precious Metals
  • BGLC Medical Specialities
  • Sector
  • CHNR Basic Materials
  • BGLC Health Care
  • Exchange
  • CHNR Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • CHNR 4.6M
  • BGLC 10.7M
  • IPO Year
  • CHNR 1995
  • BGLC N/A
  • Fundamental
  • Price
  • CHNR $3.85
  • BGLC $3.77
  • Analyst Decision
  • CHNR
  • BGLC
  • Analyst Count
  • CHNR 0
  • BGLC 0
  • Target Price
  • CHNR N/A
  • BGLC N/A
  • AVG Volume (30 Days)
  • CHNR 31.9K
  • BGLC 2.8M
  • Earning Date
  • CHNR 05-15-2025
  • BGLC 08-13-2025
  • Dividend Yield
  • CHNR N/A
  • BGLC N/A
  • EPS Growth
  • CHNR N/A
  • BGLC N/A
  • EPS
  • CHNR N/A
  • BGLC N/A
  • Revenue
  • CHNR N/A
  • BGLC $9,265,870.00
  • Revenue This Year
  • CHNR N/A
  • BGLC N/A
  • Revenue Next Year
  • CHNR N/A
  • BGLC N/A
  • P/E Ratio
  • CHNR N/A
  • BGLC N/A
  • Revenue Growth
  • CHNR N/A
  • BGLC N/A
  • 52 Week Low
  • CHNR $3.35
  • BGLC $2.01
  • 52 Week High
  • CHNR $9.04
  • BGLC $15.60
  • Technical
  • Relative Strength Index (RSI)
  • CHNR 45.91
  • BGLC 46.26
  • Support Level
  • CHNR $3.35
  • BGLC $5.33
  • Resistance Level
  • CHNR $4.04
  • BGLC $6.39
  • Average True Range (ATR)
  • CHNR 0.24
  • BGLC 1.24
  • MACD
  • CHNR 0.01
  • BGLC -0.18
  • Stochastic Oscillator
  • CHNR 46.32
  • BGLC 8.15

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: